Markus Moehler

25.8k citations
327 papers · 8.6k indexed · 3 hit papers · h-index 48
    • Gastrointestinal Tumor Research and Treatment 52
  • Oncology top 0.2%
    • Colorectal Cancer Treatments and Studies 107
    • Cancer Immunotherapy and Biomarkers 46
    • Pancreatic and Hepatic Oncology Research 31
    • Gastric Cancer Management and Outcomes 171
    • Lung Cancer Treatments and Mutations 31
  • Surgery top 1%
    • Esophageal Cancer Research and Treatment 69
    • Cholangiocarcinoma and Gallbladder Cancer Studies 44

Markus Moehler

314 papers receiving 8.5k citations

Hit Papers

Phase III, randomised trial of avelumab versus physic...3722013202620172021200400600

Peers

Markus Moehler
Comparison fields: 5 of 121
  • Gastroenterology 1.2k
  • Oncology 5.1k
  • Pulmonary and Respiratory Medicine 4.1k
  • Cancer Research 1.1k
  • Surgery 2.8k
Replace Gary Middleton with:
Gary Middleton United Kingdom
Yelena Y. Janjigian United States
Won Ki Kang South Korea
Li‐Tzong Chen Taiwan
Young Suk Park South Korea
Jean–François Fléjou France
Franco Roviello Italy
Benjamin Tan United States
Michele Orditura Italy
Joseph P. Eder United States
Markus Moehler relative to Gary Middleton United Kingdom Gary Middleton's profile →
Citations per field
00.5×1.6×
Gary Middleton · 1×
Citations per year

Countries citing papers authored by Markus Moehler

Since Specialization
Citations

This map shows the geographic impact of Markus Moehler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Moehler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Moehler more than expected).

Fields of papers citing papers by Markus Moehler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Moehler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Moehler. The network helps show where Markus Moehler may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Markus Moehler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Moehler Line = papers co-authored together Markus Moehler links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20242
3 20241
4 20242
5 20246
6 20243
7 20238
8 20235
9 20211
10 20216
11 20213
12 202020
13 202029
14 2019132
15 201813
16 2017113
17 201714
18 20146
19 201294
20
Cetuximab with irinotecan/NA-FA/5-FU as first-line treatment in advanced gastric cancer: Preliminary results of a non-randomised multi-centre AIO phase II study
20088

About Markus Moehler

Markus Moehler is a scholar working on Gastroenterology, Oncology and Pulmonary and Respiratory Medicine, having authored 327 papers that have together received 8.6k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (171 papers), Colorectal Cancer Treatments and Studies (107 papers), Esophageal Cancer Research and Treatment (69 papers), Gastrointestinal Tumor Research and Treatment (52 papers), Cancer Immunotherapy and Biomarkers (46 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (44 papers), Pancreatic and Hepatic Oncology Research (31 papers) and Lung Cancer Treatments and Mutations (31 papers). The work is most often cited by research in Gastroenterology (1.2k citations), Oncology (5.1k citations) and Pulmonary and Respiratory Medicine (4.1k citations). Markus Moehler has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Peter R. Galle, Dorothea Wagner, Florian Lordick, Ines Gockel, Wilfried Grothe, Wei Peng Yong, Jingshan Ho, Nicholas Syn, Bee‐Choo Tai and Susanne Unverzagt. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, BMC Cancer, European Journal of Cancer and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026